The pharmaceutical landscape for blood sugar is evolving, and transdermal GLP-1 delivery systems represent a potential breakthrough. Unlike subcutaneous injections, this approach offers a less invasive way to provide https://marvinyhch943208.ezblogz.com/72766529/glp-1-patches-a-innovative-approach-to-diabetes-treatment